IP Library Granted Patent US 8,685,445
Granted Patent B2
US 8,685,445 · App. 10/529,984 · Granted Apr 1, 2014

Enteric composition for the manufacture of soft capsule wall

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,685,445
App. No.
10/529,984
Granted
Apr 1, 2014
Kind
B2
Abstract

A gel mass is provided that is useful in manufacturing enteric soft or hard capsules, or enteric tablets without coating.

Claims (24)

1. An enteric soft capsule shell formed from a gel mass composition comprising

(a) a film-forming, water-soluble polymer,

(b) an acid-insoluble polymer; and

(c) an alkaline aqueous solvent;

wherein the ratio of acid-insoluble polymer to film-forming, water soluble polymer is from 30:70 to 45:55 by weight;

the final pH of the gel mass is less than or equal to about 9 pH units;

and the moisture content of the enteric soft capsule shell formed from the gel mass composition is from about 2% to about 10%.

2. The enteric soft capsule shell of claim 1 , wherein the film-forming, water-soluble polymer is proteinaceous.

3. The enteric soft capsule shell of claim 2 , wherein the proteinaceous film-forming, water-soluble polymer is gelatin.

4. The enteric soft capsule shell of claim 3 , wherein the gelatin is extracted from animal bones or skins, and has about 100 to about 250 blooms.

5. The enteric soft capsule shell of claim 1 , wherein the film-forming, water-soluble polymer is a carbohydrate.

6. The enteric soft capsule shell of claim 5 , wherein the carbohydrate is selected from the group consisting of hydroxypropyl methylcellulose and methyl cellulose.

7. The enteric soft capsule shell of claim 1 , wherein the acid-insoluble polymer is selected from the group consisting of acrylic and methacrylic acid copolymers, cellulose acetate esters, hydroxypropyl methyl cellulose phthalate, and salts thereof.

8. The enteric soft capsule shell of claim 1 , further comprising at least one plasticizer selected from the group consisting of sorbitol, glycerol, polyethylene glycol, poly-alcohols with 3 to 6 carbon atoms, citric acid, citric acid esters, triethyl citrate, and combinations thereof.

9. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent comprises an alkali selected from the group consisting of ammonia, sodium hydroxide, potassium hydroxide, ethylenediamine, hydroxylamine, and tri-ethanolamine.

10. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent comprises a volatile alkali.

11. The enteric soft capsule shell of claim 10 , wherein the volatile alkali is selected from the group consisting of ammonia and ethylenediamine.

12. The enteric soft capsule shell of claim 1 , wherein the alkaline aqueous solvent is a hydroalcoholic solution.

13. The enteric soft capsule shell of claim 1 , where the final pH of the gel mass is less than or equal to about 8.5.

14. The enteric soft capsule shell of claim 1 , wherein the enteric soft capsule shell has a moisture content of from about 2% to about 10%.

15. The enteric soft capsule shell of claim 14 , wherein the moisture content is from about 4% to about 8%.

16. The enteric soft capsule shell of claim 14 , wherein the moisture content is about 8%.

17. The enteric soft capsule shell of claim 1 , wherein the gel mass composition comprises a plasticizer, and the ratio of plasticizer to film-forming, water-soluble polymer is from about 1:9 to about 1:1 by weight.

18. The enteric soft capsule shell of claim 17 , wherein the ratio of plasticizer to film-forming, water-soluble polymer is about 1:3 by weight.

Assignments (11)
RELEASE (REEL 032403 / FRAME 0790) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BANNER PHARMACAPS INC.
Reel/Frame 044038/0028 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032403/0790) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043173/0005 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC; BANNER PHARMACAPS INC.
Reel/Frame 036224/0623 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC
Reel/Frame 036239/0188 →
SECURITY INTEREST Recorded Mar 5, 2015
From: BANNER LIFE SCIENCES LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 035133/0328 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 19, 2014
From: BANNER PHARMACAPS INC
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034294/0916 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Apr 23, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: BANNER PHARMACAPS INC.
Reel/Frame 032745/0454 →
SECURITY INTEREST Recorded Mar 11, 2014
From: BANNER PHARMACAPS INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032403/0790 →
SECURITY AGREEMENT Recorded Dec 17, 2012
From: BANNER PHARMACAPS INC.
To: MORGAN STANLEY SENIOR FUNDING INC., AS COLLATERAL AGENT
Reel/Frame 029481/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2005
From: FATMI, AQUEEL A.; HASSAN, EMADELDIN M.; CHIDAMBARAM, NACHIAPPAN
To: BANNER PHARMACAPS, INC.
Reel/Frame 016928/0712 →